Joining Merck in January 2002, Justin MOSER gained a broad understanding of drug product development from early formulation and prototyping through to NDA filing. More recently, MOSER became a scientific leader within Formulation Sciences and mentors two experienced scientists. His current role as Director of Advanced Manufacturing Technology focuses on drug product formulation, process development and scale-up and the optimization of new or existing technologies.
Dr. HOLTZ is a Life Science Value Expert at Dassault Systèmes with 20+ years of experience in the industry, working with companies such as Bayer, GSK and AstraZeneca to help them improve their business processes through digitalization.
A PhD physicist by training, Dr. HOLTZ uses her analytical skills to understand why customers are engaging with us, what drives the need to digitalize and what can be improved in terms of changing business processes, which ultimately guides how people will work tomorrow using the 3DEXPERINECE Platform and its applications.